Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas-Reference-Cited by-同舟云学术

Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas

Published:2016-08-03 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Malouf Gabriel G.,Compérat Eva,Yao Hui,Mouawad Roger,Lindner Veronique,Rioux-leclercq Nathalie,Verkarre Virginie,Leroy Xavier,Dainese Linda,Classe Marion,Descotes Jean-Luc,Barthelemy Philippe,Yacoub Mokrane,Rouprêt Morgan,Bernhard Jean-Christophe,Creighton Chad J.,Spano Jean-Philippe,Su Xiaoping,Khayat David

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep30988.pdf

Reference22 articles.

1. Kwon, K. A. et al. Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee. Cancer Res Treat 46, 141–147, 10.4143/crt.2014.46.2.141 (2014).

2. Amin, M. B. et al. Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. Am J Surg Pathol 38, 871–874, 10.1097/PAS.0000000000000222 (2014).

3. Bose, D., Das, R. N., Chatterjee, U. & Banerjee, U. Collecting duct carcinoma: a rare malignancy. J Cancer Res Ther 9, 94–95, 10.4103/0973-1482.110387 (2013).

4. Karakiewicz, P. I. et al. Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol 52, 1140–1145, 10.1016/j.eururo.2007.01.070 (2007).

5. Gonzalez-Roibon, N. et al. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas. Hum Pathol 44, 2651–2657, 10.1016/j.humpath.2013.07.006 (2013).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability;EMBO Molecular Medicine;2024-08-09

2. The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature;Critical Reviews in Oncology/Hematology;2023-08

3. Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24);European Journal of Cancer;2023-06

4. Tumeurs de Bellini et carcinomes médullaires rénaux à l’ère des nouvelles thérapies;Bulletin du Cancer;2023-04

5. Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities;The Oncologist;2023-02-06